Stephen L Sabba

CIK 1442372 · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.25M

Companies

3

Total Filings

44

Lifetime Open-Market Net

-$6.14M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LGND Director 33,629 $255.54 $8.59M -$6.14M 35 2026-06-09
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director $0 2 2018-08-13
QLTI Director 24,500 $26.82 $657.1K $0 7 2016-06-21

Recent Filings · Page 4 of 5

44 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-12-17 QLTI Exer (M) +2,000 $0 EDGAR
2014-10-14 LGND Buy (P) +2,000 $86.2K EDGAR
2014-10-10 LGND Grant (A) +2,000 $86.2K EDGAR
2014-02-28 LGND Sell (S) −500 -$36.1K EDGAR
2013-07-17 QLTI Grant (A) $0 EDGAR
2013-06-13 LGND Grant (A) +3,621 $0 EDGAR
2012-07-12 QLTI Grant (A) $0 EDGAR
2012-06-04 LGND Grant (A) +6,721 $24.0K EDGAR
2011-11-14 LGND Buy (P) +2,000 $23.2K EDGAR
2011-06-06 LGND Mixed $0 EDGAR
Showing 3140 of 44
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.